Results from a U.S. trial of AstraZeneca's COVID-19 vaccine may have included "outdated information" and that could mean the company provided an incomplete view of efficacy data, U.S. federal health officials said early Tuesday.
from CBC | Health News https://ift.tt/3ccPjq2
Aucun commentaire:
Enregistrer un commentaire